Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-06-02 00:00:00 ET · period of report 2023-06-01 · accession 0001238403-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | MYGN | SPIEGELMAN DANIEL K | Dir | A - Grant | $0.00 | +15.2K | 49.1K | +45% | $0 | |
| 2023-06-02 | 2023-06-02 | MYGN | SPIEGELMAN DANIEL K | Dir | S - Sale | $23.01 | -8,638 | 40.5K | -18% | -$198.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | A | A | 15,151 | $0.00 | 49,131 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-02 | S | D | 8,638 | $23.01 | 40,493 | D | — | — |